Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
A8704 StiripentolTarget: Lactate Dehydrogenases (LDH)Summary: An LDH inhibitor
-
A4333 CPI-6131 CitationTarget: Pyruvate dehydrogenases (PDH)Summary: PDH/α-KGDH inhibitor
-
A4351 PluriSIn #1 (NSC 14613)Target: Stearoyl-CoA 9-desaturase (SCD-1)Summary: SCD1 inhibitor
-
B5354 CGP 3466B maleateTarget: GAPDHSummary: GAPDH inhibitor
-
B5508 Alda 1Target: Aldehyde DehydrogenasesSummary: ALDH2 activator
-
B4929 GSK 2837808ATarget: Lactate Dehydrogenases (LDH)Summary: Potent, selective lactate dehydrogenase A (LDHA) inhibitor